Physician profile
Jerzy Hubert
NPI 1437563186
$3,187.06
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $734 · 2023: $1,935 · 2024: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,452.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $698.61 | 2022-2024 | |
| Alkermes, INC. | $430.11 | 2022-2024 | Lybalvi, Aristada |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $300.73 | 2022-2024 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $281.29 | 2022-2024 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $258.83 | 2022-2024 | Rexulti |
| Axsome Therapeutics, INC. | $217.34 | 2022-2024 | Auvelity |
| Neurocrine Biosciences, INC. | $186.43 | 2022-2024 | Ingrezza |
| Lundbeck LLC | $148.43 | 2022-2024 | Rexulti |
| Corium, LLC | $135.51 | 2022-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $111.74 | 2023-2024 | Jornay Pm |
| Janssen Pharmaceuticals, INC | $104.88 | 2022 | |
| Idorsia Pharmaceuticals US INC | $80.44 | 2022-2024 | Quviviq |
| Bausch Health US, LLC | $66.17 | 2022-2024 | Aplenzin |
| Supernus Pharmaceuticals, INC. | $57.79 | 2022-2023 | Qelbree |
| Biogen, INC. | $40.83 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $40.40 | 2022-2023 | Austedo |
| Tris Pharma INC | $27.53 | 2022-2024 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerzy Hubert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.